We've found
2,815
archived clinical trials in
Parkinsons Disease
We've found
2,815
archived clinical trials in
Parkinsons Disease
Nilotinib in Parkinson's Disease
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase IIa, Parallel Group, Two Cohort Study to Define the Safety, Tolerability, Clinical and Exploratory Biological Activity of the Chronic Administration of Nilotinib in Participants With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Nilotinib in Parkinson's Disease
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase IIa, Parallel Group, Two Cohort Study to Define the Safety, Tolerability, Clinical and Exploratory Biological Activity of the Chronic Administration of Nilotinib in Participants With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Nilotinib in Parkinson's Disease
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase IIa, Parallel Group, Two Cohort Study to Define the Safety, Tolerability, Clinical and Exploratory Biological Activity of the Chronic Administration of Nilotinib in Participants With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Nilotinib in Parkinson's Disease
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase IIa, Parallel Group, Two Cohort Study to Define the Safety, Tolerability, Clinical and Exploratory Biological Activity of the Chronic Administration of Nilotinib in Participants With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Nilotinib in Parkinson's Disease
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase IIa, Parallel Group, Two Cohort Study to Define the Safety, Tolerability, Clinical and Exploratory Biological Activity of the Chronic Administration of Nilotinib in Participants With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Nilotinib in Parkinson's Disease
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase IIa, Parallel Group, Two Cohort Study to Define the Safety, Tolerability, Clinical and Exploratory Biological Activity of the Chronic Administration of Nilotinib in Participants With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Nilotinib in Parkinson's Disease
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase IIa, Parallel Group, Two Cohort Study to Define the Safety, Tolerability, Clinical and Exploratory Biological Activity of the Chronic Administration of Nilotinib in Participants With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Nilotinib in Parkinson's Disease
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase IIa, Parallel Group, Two Cohort Study to Define the Safety, Tolerability, Clinical and Exploratory Biological Activity of the Chronic Administration of Nilotinib in Participants With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Nilotinib in Parkinson's Disease
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase IIa, Parallel Group, Two Cohort Study to Define the Safety, Tolerability, Clinical and Exploratory Biological Activity of the Chronic Administration of Nilotinib in Participants With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Nilotinib in Parkinson's Disease
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase IIa, Parallel Group, Two Cohort Study to Define the Safety, Tolerability, Clinical and Exploratory Biological Activity of the Chronic Administration of Nilotinib in Participants With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Nilotinib in Parkinson's Disease
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase IIa, Parallel Group, Two Cohort Study to Define the Safety, Tolerability, Clinical and Exploratory Biological Activity of the Chronic Administration of Nilotinib in Participants With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Nilotinib in Parkinson's Disease
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase IIa, Parallel Group, Two Cohort Study to Define the Safety, Tolerability, Clinical and Exploratory Biological Activity of the Chronic Administration of Nilotinib in Participants With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Nilotinib in Parkinson's Disease
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase IIa, Parallel Group, Two Cohort Study to Define the Safety, Tolerability, Clinical and Exploratory Biological Activity of the Chronic Administration of Nilotinib in Participants With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Nilotinib in Parkinson's Disease
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase IIa, Parallel Group, Two Cohort Study to Define the Safety, Tolerability, Clinical and Exploratory Biological Activity of the Chronic Administration of Nilotinib in Participants With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Nilotinib in Parkinson's Disease
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase IIa, Parallel Group, Two Cohort Study to Define the Safety, Tolerability, Clinical and Exploratory Biological Activity of the Chronic Administration of Nilotinib in Participants With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Nilotinib in Parkinson's Disease
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase IIa, Parallel Group, Two Cohort Study to Define the Safety, Tolerability, Clinical and Exploratory Biological Activity of the Chronic Administration of Nilotinib in Participants With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Nilotinib in Parkinson's Disease
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase IIa, Parallel Group, Two Cohort Study to Define the Safety, Tolerability, Clinical and Exploratory Biological Activity of the Chronic Administration of Nilotinib in Participants With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Nilotinib in Parkinson's Disease
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase IIa, Parallel Group, Two Cohort Study to Define the Safety, Tolerability, Clinical and Exploratory Biological Activity of the Chronic Administration of Nilotinib in Participants With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Nilotinib in Parkinson's Disease
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase IIa, Parallel Group, Two Cohort Study to Define the Safety, Tolerability, Clinical and Exploratory Biological Activity of the Chronic Administration of Nilotinib in Participants With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Nilotinib in Parkinson's Disease
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase IIa, Parallel Group, Two Cohort Study to Define the Safety, Tolerability, Clinical and Exploratory Biological Activity of the Chronic Administration of Nilotinib in Participants With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Nilotinib in Parkinson's Disease
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase IIa, Parallel Group, Two Cohort Study to Define the Safety, Tolerability, Clinical and Exploratory Biological Activity of the Chronic Administration of Nilotinib in Participants With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Nilotinib in Parkinson's Disease
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase IIa, Parallel Group, Two Cohort Study to Define the Safety, Tolerability, Clinical and Exploratory Biological Activity of the Chronic Administration of Nilotinib in Participants With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Nilotinib in Parkinson's Disease
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase IIa, Parallel Group, Two Cohort Study to Define the Safety, Tolerability, Clinical and Exploratory Biological Activity of the Chronic Administration of Nilotinib in Participants With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Nilotinib in Parkinson's Disease
Updated: 12/31/1969
A Randomized, Double-Blind, Placebo-Controlled, Phase IIa, Parallel Group, Two Cohort Study to Define the Safety, Tolerability, Clinical and Exploratory Biological Activity of the Chronic Administration of Nilotinib in Participants With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ITI-214 in Parkinson's Disease
Updated: 12/31/1969
A Randomized, Placebo-Controlled, Double-Blind Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of ITI-214 in Patients With Idiopathic Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ITI-214 in Parkinson's Disease
Updated: 12/31/1969
A Randomized, Placebo-Controlled, Double-Blind Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of ITI-214 in Patients With Idiopathic Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ITI-214 in Parkinson's Disease
Updated: 12/31/1969
A Randomized, Placebo-Controlled, Double-Blind Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of ITI-214 in Patients With Idiopathic Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ITI-214 in Parkinson's Disease
Updated: 12/31/1969
A Randomized, Placebo-Controlled, Double-Blind Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of ITI-214 in Patients With Idiopathic Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
Updated: 12/31/1969
An Open-label Safety and Efficacy Study of VY-AADC01 Administered by MRI-Guided Convective Infusion Using a Posterior Trajectory Into the Putamen of Participants With Parkinson's Disease With Fluctuating Responses to Levodopa
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
Updated: 12/31/1969
An Open-label Safety and Efficacy Study of VY-AADC01 Administered by MRI-Guided Convective Infusion Using a Posterior Trajectory Into the Putamen of Participants With Parkinson's Disease With Fluctuating Responses to Levodopa
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
Updated: 12/31/1969
An Open-label Safety and Efficacy Study of VY-AADC01 Administered by MRI-Guided Convective Infusion Using a Posterior Trajectory Into the Putamen of Participants With Parkinson's Disease With Fluctuating Responses to Levodopa
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
Updated: 12/31/1969
An Open-label Safety and Efficacy Study of VY-AADC01 Administered by MRI-Guided Convective Infusion Using a Posterior Trajectory Into the Putamen of Participants With Parkinson's Disease With Fluctuating Responses to Levodopa
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
Updated: 12/31/1969
An Open-label Safety and Efficacy Study of VY-AADC01 Administered by MRI-Guided Convective Infusion Using a Posterior Trajectory Into the Putamen of Participants With Parkinson's Disease With Fluctuating Responses to Levodopa
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
Updated: 12/31/1969
An Open-label Safety and Efficacy Study of VY-AADC01 Administered by MRI-Guided Convective Infusion Using a Posterior Trajectory Into the Putamen of Participants With Parkinson's Disease With Fluctuating Responses to Levodopa
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
Updated: 12/31/1969
An Open-label Safety and Efficacy Study of VY-AADC01 Administered by MRI-Guided Convective Infusion Using a Posterior Trajectory Into the Putamen of Participants With Parkinson's Disease With Fluctuating Responses to Levodopa
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
Updated: 12/31/1969
An Open-label Safety and Efficacy Study of VY-AADC01 Administered by MRI-Guided Convective Infusion Using a Posterior Trajectory Into the Putamen of Participants With Parkinson's Disease With Fluctuating Responses to Levodopa
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes
Updated: 12/31/1969
A Phase 2, Randomized, Double-Blind, Placebo Controlled, 3-Period Crossover, Positive Control, QT-Evaluation Study of APL-130277 in Subjects With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)
Status: Enrolling
Updated: 12/31/1969
A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes
Updated: 12/31/1969
A Phase 2, Randomized, Double-Blind, Placebo Controlled, 3-Period Crossover, Positive Control, QT-Evaluation Study of APL-130277 in Subjects With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes
Updated: 12/31/1969
A Phase 2, Randomized, Double-Blind, Placebo Controlled, 3-Period Crossover, Positive Control, QT-Evaluation Study of APL-130277 in Subjects With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)
Status: Enrolling
Updated: 12/31/1969
A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes
Updated: 12/31/1969
A Phase 2, Randomized, Double-Blind, Placebo Controlled, 3-Period Crossover, Positive Control, QT-Evaluation Study of APL-130277 in Subjects With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes
Updated: 12/31/1969
A Phase 2, Randomized, Double-Blind, Placebo Controlled, 3-Period Crossover, Positive Control, QT-Evaluation Study of APL-130277 in Subjects With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)
Status: Enrolling
Updated: 12/31/1969
A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes
Updated: 12/31/1969
A Phase 2, Randomized, Double-Blind, Placebo Controlled, 3-Period Crossover, Positive Control, QT-Evaluation Study of APL-130277 in Subjects With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes
Updated: 12/31/1969
A Phase 2, Randomized, Double-Blind, Placebo Controlled, 3-Period Crossover, Positive Control, QT-Evaluation Study of APL-130277 in Subjects With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)
Status: Enrolling
Updated: 12/31/1969
A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes
Updated: 12/31/1969
A Phase 2, Randomized, Double-Blind, Placebo Controlled, 3-Period Crossover, Positive Control, QT-Evaluation Study of APL-130277 in Subjects With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes
Updated: 12/31/1969
A Phase 2, Randomized, Double-Blind, Placebo Controlled, 3-Period Crossover, Positive Control, QT-Evaluation Study of APL-130277 in Subjects With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)
Status: Enrolling
Updated: 12/31/1969
A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes
Updated: 12/31/1969
A Phase 2, Randomized, Double-Blind, Placebo Controlled, 3-Period Crossover, Positive Control, QT-Evaluation Study of APL-130277 in Subjects With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes
Updated: 12/31/1969
A Phase 2, Randomized, Double-Blind, Placebo Controlled, 3-Period Crossover, Positive Control, QT-Evaluation Study of APL-130277 in Subjects With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)
Status: Enrolling
Updated: 12/31/1969
A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes
Updated: 12/31/1969
A Phase 2, Randomized, Double-Blind, Placebo Controlled, 3-Period Crossover, Positive Control, QT-Evaluation Study of APL-130277 in Subjects With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes
Updated: 12/31/1969
A Phase 2, Randomized, Double-Blind, Placebo Controlled, 3-Period Crossover, Positive Control, QT-Evaluation Study of APL-130277 in Subjects With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)
Status: Enrolling
Updated: 12/31/1969
A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes
Updated: 12/31/1969
A Phase 2, Randomized, Double-Blind, Placebo Controlled, 3-Period Crossover, Positive Control, QT-Evaluation Study of APL-130277 in Subjects With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes
Updated: 12/31/1969
A Phase 2, Randomized, Double-Blind, Placebo Controlled, 3-Period Crossover, Positive Control, QT-Evaluation Study of APL-130277 in Subjects With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)
Status: Enrolling
Updated: 12/31/1969
A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes
Updated: 12/31/1969
A Phase 2, Randomized, Double-Blind, Placebo Controlled, 3-Period Crossover, Positive Control, QT-Evaluation Study of APL-130277 in Subjects With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes
Updated: 12/31/1969
A Phase 2, Randomized, Double-Blind, Placebo Controlled, 3-Period Crossover, Positive Control, QT-Evaluation Study of APL-130277 in Subjects With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)
Status: Enrolling
Updated: 12/31/1969
A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes
Updated: 12/31/1969
A Phase 2, Randomized, Double-Blind, Placebo Controlled, 3-Period Crossover, Positive Control, QT-Evaluation Study of APL-130277 in Subjects With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes
Updated: 12/31/1969
A Phase 2, Randomized, Double-Blind, Placebo Controlled, 3-Period Crossover, Positive Control, QT-Evaluation Study of APL-130277 in Subjects With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)
Status: Enrolling
Updated: 12/31/1969
A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes
Updated: 12/31/1969
A Phase 2, Randomized, Double-Blind, Placebo Controlled, 3-Period Crossover, Positive Control, QT-Evaluation Study of APL-130277 in Subjects With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes
Updated: 12/31/1969
A Phase 2, Randomized, Double-Blind, Placebo Controlled, 3-Period Crossover, Positive Control, QT-Evaluation Study of APL-130277 in Subjects With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)
Status: Enrolling
Updated: 12/31/1969
A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes
Updated: 12/31/1969
A Phase 2, Randomized, Double-Blind, Placebo Controlled, 3-Period Crossover, Positive Control, QT-Evaluation Study of APL-130277 in Subjects With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Effectiveness of Botox on Reducing Rest Tremor in Parkinson's Disease
Updated: 12/31/1969
Effectiveness of Onabotulinumtoxin A on Reduction of Rest Tremor in Parkinson's Disease: a Pilot Study
Status: Enrolling
Updated: 12/31/1969
Effectiveness of Botox on Reducing Rest Tremor in Parkinson's Disease
Updated: 12/31/1969
Effectiveness of Onabotulinumtoxin A on Reduction of Rest Tremor in Parkinson's Disease: a Pilot Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Lipiflow Versus Warm Compresses in Parkinson's Disease
Updated: 12/31/1969
Prospective Fellow Eye Comparison of Traditional Meibomian Gland Disease Treatment Versus a Single Thermal Pulsation Treatment in Patients With Parkinsons Disease
Status: Enrolling
Updated: 12/31/1969
Lipiflow Versus Warm Compresses in Parkinson's Disease
Updated: 12/31/1969
Prospective Fellow Eye Comparison of Traditional Meibomian Gland Disease Treatment Versus a Single Thermal Pulsation Treatment in Patients With Parkinsons Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Telephone-linked Home-based Exercise Training in PD
Updated: 12/31/1969
Telephone-linked Home-based Exercise Training in PD
Status: Enrolling
Updated: 12/31/1969
Telephone-linked Home-based Exercise Training in PD
Updated: 12/31/1969
Telephone-linked Home-based Exercise Training in PD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Buspirone in Parkinson's Disease
Updated: 12/31/1969
The Tolerability of Buspirone for the Treatment of Anxiety in Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Buspirone in Parkinson's Disease
Updated: 12/31/1969
The Tolerability of Buspirone for the Treatment of Anxiety in Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cognitive Rehabilitation for PD-MCI
Updated: 12/31/1969
Cognitive Rehabilitation for Individuals With Parkinson's Disease and MCI
Status: Enrolling
Updated: 12/31/1969
Cognitive Rehabilitation for PD-MCI
Updated: 12/31/1969
Cognitive Rehabilitation for Individuals With Parkinson's Disease and MCI
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Invasive TMS Neuromodulation for Enduring Balance & Locomotion Restoration in Parkinson's Disease
Updated: 12/31/1969
Non-Invasive TMS Neuromodulation for Enduring Balance & Locomotion Restoration in Parkinson's Disease: A Feasibility and Pilot Study (Locom-TMS)
Status: Enrolling
Updated: 12/31/1969
Non-Invasive TMS Neuromodulation for Enduring Balance & Locomotion Restoration in Parkinson's Disease
Updated: 12/31/1969
Non-Invasive TMS Neuromodulation for Enduring Balance & Locomotion Restoration in Parkinson's Disease: A Feasibility and Pilot Study (Locom-TMS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Transcutaneous Submandibular Gland Biopsy: Feasibility of Repeat Biopsy as a Progression Marker for Parkinson's Disease
Updated: 12/31/1969
Transcutaneous Submandibular Gland Biopsy: Feasibility of Repeat Biopsy as a Progression Marker for Parkinson&Apos;s Disease
Status: Enrolling
Updated: 12/31/1969
Transcutaneous Submandibular Gland Biopsy: Feasibility of Repeat Biopsy as a Progression Marker for Parkinson's Disease
Updated: 12/31/1969
Transcutaneous Submandibular Gland Biopsy: Feasibility of Repeat Biopsy as a Progression Marker for Parkinson&Apos;s Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Videofluoroscopic Swallowing Study (VFSS)
Updated: 12/31/1969
A Prospective Multi-center Study Comparing the Performance of the Dysphagia Detection System (DDS) in Detecting Impaired Swallowing Safety and Efficiency as Compared to the Clinical Reference Method - Videofluoroscopic Swallowing Study
Status: Enrolling
Updated: 12/31/1969
Videofluoroscopic Swallowing Study (VFSS)
Updated: 12/31/1969
A Prospective Multi-center Study Comparing the Performance of the Dysphagia Detection System (DDS) in Detecting Impaired Swallowing Safety and Efficiency as Compared to the Clinical Reference Method - Videofluoroscopic Swallowing Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Videofluoroscopic Swallowing Study (VFSS)
Updated: 12/31/1969
A Prospective Multi-center Study Comparing the Performance of the Dysphagia Detection System (DDS) in Detecting Impaired Swallowing Safety and Efficiency as Compared to the Clinical Reference Method - Videofluoroscopic Swallowing Study
Status: Enrolling
Updated: 12/31/1969
Videofluoroscopic Swallowing Study (VFSS)
Updated: 12/31/1969
A Prospective Multi-center Study Comparing the Performance of the Dysphagia Detection System (DDS) in Detecting Impaired Swallowing Safety and Efficiency as Compared to the Clinical Reference Method - Videofluoroscopic Swallowing Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Videofluoroscopic Swallowing Study (VFSS)
Updated: 12/31/1969
A Prospective Multi-center Study Comparing the Performance of the Dysphagia Detection System (DDS) in Detecting Impaired Swallowing Safety and Efficiency as Compared to the Clinical Reference Method - Videofluoroscopic Swallowing Study
Status: Enrolling
Updated: 12/31/1969
Videofluoroscopic Swallowing Study (VFSS)
Updated: 12/31/1969
A Prospective Multi-center Study Comparing the Performance of the Dysphagia Detection System (DDS) in Detecting Impaired Swallowing Safety and Efficiency as Compared to the Clinical Reference Method - Videofluoroscopic Swallowing Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Videofluoroscopic Swallowing Study (VFSS)
Updated: 12/31/1969
A Prospective Multi-center Study Comparing the Performance of the Dysphagia Detection System (DDS) in Detecting Impaired Swallowing Safety and Efficiency as Compared to the Clinical Reference Method - Videofluoroscopic Swallowing Study
Status: Enrolling
Updated: 12/31/1969
Videofluoroscopic Swallowing Study (VFSS)
Updated: 12/31/1969
A Prospective Multi-center Study Comparing the Performance of the Dysphagia Detection System (DDS) in Detecting Impaired Swallowing Safety and Efficiency as Compared to the Clinical Reference Method - Videofluoroscopic Swallowing Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Videofluoroscopic Swallowing Study (VFSS)
Updated: 12/31/1969
A Prospective Multi-center Study Comparing the Performance of the Dysphagia Detection System (DDS) in Detecting Impaired Swallowing Safety and Efficiency as Compared to the Clinical Reference Method - Videofluoroscopic Swallowing Study
Status: Enrolling
Updated: 12/31/1969
Videofluoroscopic Swallowing Study (VFSS)
Updated: 12/31/1969
A Prospective Multi-center Study Comparing the Performance of the Dysphagia Detection System (DDS) in Detecting Impaired Swallowing Safety and Efficiency as Compared to the Clinical Reference Method - Videofluoroscopic Swallowing Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Videofluoroscopic Swallowing Study (VFSS)
Updated: 12/31/1969
A Prospective Multi-center Study Comparing the Performance of the Dysphagia Detection System (DDS) in Detecting Impaired Swallowing Safety and Efficiency as Compared to the Clinical Reference Method - Videofluoroscopic Swallowing Study
Status: Enrolling
Updated: 12/31/1969
Videofluoroscopic Swallowing Study (VFSS)
Updated: 12/31/1969
A Prospective Multi-center Study Comparing the Performance of the Dysphagia Detection System (DDS) in Detecting Impaired Swallowing Safety and Efficiency as Compared to the Clinical Reference Method - Videofluoroscopic Swallowing Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Videofluoroscopic Swallowing Study (VFSS)
Updated: 12/31/1969
A Prospective Multi-center Study Comparing the Performance of the Dysphagia Detection System (DDS) in Detecting Impaired Swallowing Safety and Efficiency as Compared to the Clinical Reference Method - Videofluoroscopic Swallowing Study
Status: Enrolling
Updated: 12/31/1969
Videofluoroscopic Swallowing Study (VFSS)
Updated: 12/31/1969
A Prospective Multi-center Study Comparing the Performance of the Dysphagia Detection System (DDS) in Detecting Impaired Swallowing Safety and Efficiency as Compared to the Clinical Reference Method - Videofluoroscopic Swallowing Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Videofluoroscopic Swallowing Study (VFSS)
Updated: 12/31/1969
A Prospective Multi-center Study Comparing the Performance of the Dysphagia Detection System (DDS) in Detecting Impaired Swallowing Safety and Efficiency as Compared to the Clinical Reference Method - Videofluoroscopic Swallowing Study
Status: Enrolling
Updated: 12/31/1969
Videofluoroscopic Swallowing Study (VFSS)
Updated: 12/31/1969
A Prospective Multi-center Study Comparing the Performance of the Dysphagia Detection System (DDS) in Detecting Impaired Swallowing Safety and Efficiency as Compared to the Clinical Reference Method - Videofluoroscopic Swallowing Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Videofluoroscopic Swallowing Study (VFSS)
Updated: 12/31/1969
A Prospective Multi-center Study Comparing the Performance of the Dysphagia Detection System (DDS) in Detecting Impaired Swallowing Safety and Efficiency as Compared to the Clinical Reference Method - Videofluoroscopic Swallowing Study
Status: Enrolling
Updated: 12/31/1969
Videofluoroscopic Swallowing Study (VFSS)
Updated: 12/31/1969
A Prospective Multi-center Study Comparing the Performance of the Dysphagia Detection System (DDS) in Detecting Impaired Swallowing Safety and Efficiency as Compared to the Clinical Reference Method - Videofluoroscopic Swallowing Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Videofluoroscopic Swallowing Study (VFSS)
Updated: 12/31/1969
A Prospective Multi-center Study Comparing the Performance of the Dysphagia Detection System (DDS) in Detecting Impaired Swallowing Safety and Efficiency as Compared to the Clinical Reference Method - Videofluoroscopic Swallowing Study
Status: Enrolling
Updated: 12/31/1969
Videofluoroscopic Swallowing Study (VFSS)
Updated: 12/31/1969
A Prospective Multi-center Study Comparing the Performance of the Dysphagia Detection System (DDS) in Detecting Impaired Swallowing Safety and Efficiency as Compared to the Clinical Reference Method - Videofluoroscopic Swallowing Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Videofluoroscopic Swallowing Study (VFSS)
Updated: 12/31/1969
A Prospective Multi-center Study Comparing the Performance of the Dysphagia Detection System (DDS) in Detecting Impaired Swallowing Safety and Efficiency as Compared to the Clinical Reference Method - Videofluoroscopic Swallowing Study
Status: Enrolling
Updated: 12/31/1969
Videofluoroscopic Swallowing Study (VFSS)
Updated: 12/31/1969
A Prospective Multi-center Study Comparing the Performance of the Dysphagia Detection System (DDS) in Detecting Impaired Swallowing Safety and Efficiency as Compared to the Clinical Reference Method - Videofluoroscopic Swallowing Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Videofluoroscopic Swallowing Study (VFSS)
Updated: 12/31/1969
A Prospective Multi-center Study Comparing the Performance of the Dysphagia Detection System (DDS) in Detecting Impaired Swallowing Safety and Efficiency as Compared to the Clinical Reference Method - Videofluoroscopic Swallowing Study
Status: Enrolling
Updated: 12/31/1969
Videofluoroscopic Swallowing Study (VFSS)
Updated: 12/31/1969
A Prospective Multi-center Study Comparing the Performance of the Dysphagia Detection System (DDS) in Detecting Impaired Swallowing Safety and Efficiency as Compared to the Clinical Reference Method - Videofluoroscopic Swallowing Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Videofluoroscopic Swallowing Study (VFSS)
Updated: 12/31/1969
A Prospective Multi-center Study Comparing the Performance of the Dysphagia Detection System (DDS) in Detecting Impaired Swallowing Safety and Efficiency as Compared to the Clinical Reference Method - Videofluoroscopic Swallowing Study
Status: Enrolling
Updated: 12/31/1969
Videofluoroscopic Swallowing Study (VFSS)
Updated: 12/31/1969
A Prospective Multi-center Study Comparing the Performance of the Dysphagia Detection System (DDS) in Detecting Impaired Swallowing Safety and Efficiency as Compared to the Clinical Reference Method - Videofluoroscopic Swallowing Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
eOnOff - D1 Extension
Updated: 12/31/1969
Evaluation of the eON-OFF Mobile Application and Four Actigraphy Devices in Subjects With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
eOnOff - D1 Extension
Updated: 12/31/1969
Evaluation of the eON-OFF Mobile Application and Four Actigraphy Devices in Subjects With Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials